Article Details

Arcturus Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Retrieved on: 2024-04-22 21:30:44

Tags for this article:

Click the tags to see associated articles and topics

Arcturus Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4). View article details on hiswai:

Excerpt

... mRNA Technology and (iii) mRNA drug substance along with drug product manufacturing expertise. Arcturus' diverse pipeline of RNA therapeutic and ...

Article found on: www.theglobeandmail.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up